Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer

Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer

Opis bibliograficzny
Główni autorzy:	Rea, D, Gray, R, Bowden, S, Handley, K, Earl, H, Poole, C, Bates, T, Dewar, J, Raytor, Z, Lee, M
Format:	Conference item
Wydane:	2013

Podobne zapisy

Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study
od: Dennis C. Sgroi, i wsp.
Wydane: (2022-12-01)

An Extraordinary New Toad (Bufo) ttom Costa Rica
od: Jay M Savage
Wydane: (2002-06-01)

Tamoxifen-independent recombination in the RIP-CreER mouse.
od: Yanmei Liu, i wsp.
Wydane: (2010-10-01)

Testing the untestable in language education /
od: Paran, Amos, i wsp.
Wydane: (c201)

Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals
od: Joonatan Palmu, i wsp.
Wydane: (2020-08-01)

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer
od: Liu Y, i wsp.
Wydane: (2020-08-01)

Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model
od: Angel Pulido-Capiz, i wsp.
Wydane: (2024-09-01)

Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer
od: Coralie Poulard, i wsp.
Wydane: (2023-07-01)

A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia
od: Weili He, i wsp.
Wydane: (2023-03-01)

USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα
od: Ting Zhuang, i wsp.
Wydane: (2024-08-01)

Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer
od: Angela Maselli, i wsp.
Wydane: (2019-07-01)

Dynamic surveillance of tamoxifen‐resistance in ER‐positive breast cancer by CAIX‐targeted ultrasound imaging
od: Ying Li, i wsp.
Wydane: (2020-04-01)

A novel bystander effect in tamoxifen treatment: PPIB derived from ER+ cells attenuates ER− cells via endoplasmic reticulum stress-induced apoptosis
od: Tinglin Yang, i wsp.
Wydane: (2024-02-01)

FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
od: Lukasz Turczyk, i wsp.
Wydane: (2017-10-01)

δEF1 down-regulates ER-α expression and confers tamoxifen resistance in breast cancer.
od: Shaocong Guo, i wsp.
Wydane: (2012-01-01)

Five years of tamoxifen--or more?
od: Peto, R
Wydane: (1996)

Highlights of the first twenty years of the ERS, 1990-2010 past presidents of the ERS recall activities during their term of office
od: Donner Claudio F
Wydane: (2010-02-01)

ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways.
od: Sheng-Li Lin, i wsp.
Wydane: (2010-02-01)

Video er TV er video
od: Susanna Neimann
Wydane: (1988-08-01)

ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups
od: Young Choi, i wsp.
Wydane: (2022-04-01)

NR4A1 Regulates Tamoxifen Resistance by Suppressing ERK Signaling in ER-Positive Breast Cancer
od: Yu Cheon Kim, i wsp.
Wydane: (2021-06-01)

circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells
od: Zheng Li, i wsp.
Wydane: (2023-07-01)

Estrogen Receptor (ER)-α36 Is Involved in Estrogen- and Tamoxifen-Induced Neuroprotective Effects in Ischemic Stroke Models.
od: Wei Zou, i wsp.
Wydane: (2015-01-01)

Genome-wide analysis of therapeutic response uncovers molecular pathways governing tamoxifen resistance in ER+ breast cancer
od: Sarra M. Rahem, i wsp.
Wydane: (2020-11-01)

Integrative Analysis of Response to Tamoxifen Treatment in ER-Positive Breast Cancer Using GWAS Information and Transcription Profiling
od: Chindo Hicks, i wsp.
Wydane: (2012-02-01)

Untested natural medicines are big threats to health in China and Africa
od: Minghui Zhang
Wydane: (2020-07-01)

Peculiarities of gastroduodenal pathology in children in the families of parents with untested dyspepsia
od: V. V. Tsukanov, i wsp.
Wydane: (2019-07-01)

Diallel analysis and prediction of untested maize single cross hybrids
od: José Lidércio Matias Júnior, i wsp.
Wydane: (2019-02-01)

ASCLD statement on volume of untested sexual assault evidence kits
od: Laura Sudkamp, i wsp.
Wydane: (2020-01-01)

WHO-ERS train the trainer in smoking cessation: Three years' experience
od: Paraskevi Katsaounou
Wydane: (2019-10-01)

First preclinical SPECT/CT imaging and biodistribution of [165Er]ErCl3 and [165Er]Er-PSMA-617
od: Behrad Saeedi Saghez, i wsp.
Wydane: (2024-12-01)

Polarity protein SCRIB interacts with SLC3A2 to regulate proliferation and tamoxifen resistance in ER+ breast cancer
od: Yasuhiro Saito, i wsp.
Wydane: (2022-05-01)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
od: Hennekens, C, i wsp.
Wydane: (2006)

Deimplementing Untested Practices in Homecare Services: A Preobservational-Postobservational Design
od: Manon Guay, i wsp.
Wydane: (2019-01-01)

Impact on arsenic exposure of a growing proportion of untested wells in Bangladesh
od: George Christine, i wsp.
Wydane: (2012-02-01)

Who Is Classified as Untestable on Brief Cognitive Screens in an Acute Stroke Setting?
od: Emma Elliott, i wsp.
Wydane: (2019-08-01)

Untested assumptions: psychological research and credibility assessment in legal decision-making
od: Jane Herlihy, i wsp.
Wydane: (2015-05-01)

ER Stress-Sensor Proteins and ER-Mitochondrial Crosstalk—Signaling Beyond (ER) Stress Response
od: Vaishali Kumar, i wsp.
Wydane: (2021-01-01)

ER-Phagy and Its Role in ER Homeostasis in Plants
od: Yan Bao, i wsp.
Wydane: (2020-12-01)

Stort er velgjort – eller småt er godt?
od: Gunnar Lind Haase Svendsen, i wsp.
Wydane: (2018-10-01)